NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $914 | -90.9% | 8,975 | -91.9% | 0.00% | -90.9% |
Q4 2022 | $10,078 | -99.8% | 111,100 | +82.3% | 0.01% | +120.0% |
Q3 2022 | $4,633,000 | +121.4% | 60,959 | +146.1% | 0.01% | +150.0% |
Q2 2022 | $2,093,000 | -61.5% | 24,765 | -60.0% | 0.00% | -60.0% |
Q1 2022 | $5,436,000 | -47.3% | 61,959 | -47.4% | 0.01% | -50.0% |
Q4 2021 | $10,309,000 | +2414.4% | 117,859 | +2533.7% | 0.01% | – |
Q3 2021 | $410,000 | +0.5% | 4,475 | 0.0% | 0.00% | – |
Q2 2021 | $408,000 | -88.4% | 4,475 | -88.0% | 0.00% | -100.0% |
Q4 2019 | $3,530,000 | +255.1% | 37,282 | +178.5% | 0.01% | -81.4% |
Q1 2017 | $994,000 | +324.8% | 13,385 | +351.1% | 0.04% | +168.8% |
Q3 2016 | $234,000 | -42.9% | 2,967 | -40.4% | 0.02% | -40.7% |
Q2 2016 | $410,000 | -32.7% | 4,976 | -40.8% | 0.03% | -44.9% |
Q1 2016 | $609,000 | +135.1% | 8,409 | +178.8% | 0.05% | +145.0% |
Q4 2015 | $259,000 | -68.4% | 3,016 | -66.2% | 0.02% | -66.7% |
Q3 2015 | $820,000 | +1573.5% | 8,922 | +1688.0% | 0.06% | +1400.0% |
Q2 2015 | $49,000 | – | 499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |